TTrialPathMatch Me to Trials
← Back to trials
RecruitingType 2 Diabetes Mellitus (T2DM)Type 1 Diabetes Mellitus (T1DM)Hyperglycemia

Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study aims to improve patient awareness of the utility of continuous glucose monitoring systems in blood glucose monitoring and to improve patient satisfaction regarding diabetes care, particularly in the matter of blood glucose monitoring, at the transitions of care from the inpatient setting to the ambulatory setting.

Sponsor: Vanderbilt University Medical Center

You may qualify if…

  • ✓ Non-pregnant adults, ages greater than or equal to 18 years, admitted to VUMC
  • ✓ Able to give informed consent
  • ✓ Hyperglycemia requiring insulin therapy including subcutaneous insulin injection or continuous subcutaneous insulin infusion (patient's own insulin pump) during hospitalization and at the time of discharge
  • ✓ POC glucose or venous glucose levels in the 24 hours prior to participation need to be 70-350 mg/dL
  • ✓ Need glucose readings greater than or equal to one time per day
  • ✓ Mental status and dexterity adequate to use Libre 3 Plus or Dexcom G7 sensors with Libre 3 or Dexcom G7 application on patient's smartphone

You may not qualify if…

  • ✕ Currently using Libre 3 Plus or Dexcom G7 CGMS during hospitalization or have used Libre 3 Plus or Dexcom G7 CGMS in the past 3 months
  • ✕ Does not have smartphone compatible with Libre 3 App or Dexcom G7 App
  • ✕ Received chemotherapy during current hospitalization
  • ✕ Planning on major surgery within 10-15 days
  • ✕ Hemodialysis or peritoneal dialysis
  • ✕ Requiring vasopressors, intubation, sedation, or admission to an intensive care unit
  • ✕ Vitamin C use of more than 500 milligrams per day
  • ✕ Hydroxyurea use

Where it's recruiting

Tennessee

Nashville

Source: ClinicalTrials.gov · NCT06852950 · last updated 2026-03-05